261 related articles for article (PubMed ID: 18682539)
1. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
Sokolski KN; Gripeos D
Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
[No Abstract] [Full Text] [Related]
2. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
Nagoshi Y; Tominaga T; Fukui K
J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
[No Abstract] [Full Text] [Related]
3. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
4. A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
Arnold KK; Yager J
J Clin Psychiatry; 2007 Oct; 68(10):1620-1. PubMed ID: 17960985
[No Abstract] [Full Text] [Related]
5. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
Fava M; Mischoulon D; Iosifescu D; Witte J; Pencina M; Flynn M; Harper L; Levy M; Rickels K; Pollack M
Psychother Psychosom; 2012; 81(2):87-97. PubMed ID: 22286203
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
Huang LC; Chiang KT
J Clin Psychopharmacol; 2011 Jun; 31(3):376-7. PubMed ID: 21532363
[No Abstract] [Full Text] [Related]
7. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
[TBL] [Abstract][Full Text] [Related]
8. Nowhere patients.
Tomba E
Psychother Psychosom; 2012; 81(2):69-72. PubMed ID: 22261819
[No Abstract] [Full Text] [Related]
9. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Sarkar R; Klein J; Krüger S
Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
[No Abstract] [Full Text] [Related]
10. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
Bourin M; Chenu F; Prica C; Hascoët M
Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
Pessina E; Albert U; Bogetto F; Maina G
Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
[No Abstract] [Full Text] [Related]
13. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.
Rutherford B; Sneed J; Miyazaki M; Eisenstadt R; Devanand D; Sackeim H; Roose S
Int J Geriatr Psychiatry; 2007 Oct; 22(10):986-91. PubMed ID: 17340654
[TBL] [Abstract][Full Text] [Related]
14. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole augmentation for a patient with partial remission of panic disorder.
Harada T; Yamada K; Sakamoto K; Ishigooka J
J Clin Psychopharmacol; 2009 Jun; 29(3):301-2. PubMed ID: 19440089
[No Abstract] [Full Text] [Related]
17. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
Simon JS; Nemeroff CB
J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
Carter WG; Shillcutt SD
J Clin Psychiatry; 2006 Aug; 67(8):1311. PubMed ID: 16965218
[No Abstract] [Full Text] [Related]
19. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
[TBL] [Abstract][Full Text] [Related]
20. An aripiprazole discontinuation syndrome.
Philip NS
R I Med J (2013); 2013 Feb; 96(2):13-4. PubMed ID: 24933746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
